Jeantet advises Sartorius Stedim Biotech on the acquisition of Novasep’s chromatography process equipment division

 

Paris, 6 January 2021 – Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, today announced it has entered into an agreement to acquire the chromatography process equipment division of Novasep. The parties agreed not to disclose the purchase price until the necessary regulatory approvals have been obtained.

Novasep’s division expects to generate sales revenue of approximately 37 million euros in 2020 at double-digit profit margins and employs approximately 100 people, the majority of whom work at its Pompey site in northern France and some in the USA, China and India. The proposed transaction is subject to antitrust approvals and the information and consultation of Novasep’s works council and is expected to close during the first half of 2021.

Sartorius Stedim Biotech is a leading international partner of the biopharmaceutical industry. As a total solutions provider, the company helps its customers to manufacture biotech medications safely, rapidly and economically. Headquartered in Aubagne, France, Sartorius Stedim Biotech is quoted on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and an international network of sales companies, Sartorius Stedim Biotech has a global reach. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions of complementary technologies. In 2019, the company employed approx. 6,200 people, and earned sales revenue of 1,440.6 million euros.

Novasep is a global provider of cost-effective and sustainable manufacturing solutions for life sciences molecules and fine chemicals. Novasep’s unique offering includes process development services, purification equipment and turnkey processes, contract manufacturing services and complex active molecules to serve pharmaceutical, biopharmaceutical, fine chemical, food and functional ingredients, as well as fermentation and chemical commodities industries.

Sartorius Stedim Biotech was advised by Jeantet with a team lead by Karl Hepp de Sevelinges (partner, Corporate/M&A), including Michael Samol (counsel, Corporate/M&A), Robert d’Orglandes (associate, Corporate/M&A), Laetitia Ternisien (counsel, Employment) and Gabriel di Chiara (counsel, Tax).

The firm Milbank LLP has worked closely with Jeantet, notably with Michael Bernhardt (partner, Corporate/M&A) and Alexander Rinne (partner, Antitrust), as well as the firm GvW Graf von Westphalen for Chinese law aspects.

Novasep was advised by White & Case LLP with a team lead by François Leloup (partner, Corporate/M&A), including Delphin Boucher (counsel, Corporate/M&A), Alexandre Jaurett (partner, Employment) and Orion Berg (counsel, Regulatory). Teams in the New-York and Washington offices have been involved on US law aspects and a team in the Shanghai office has been involved on Chinese law aspects.

Our last press releases

Jeantet advised ANANDA IMPACT VENTURES and CONTRARIAN VENTURES on the EUR 3.6 million SSED round of DECADE ENERGY

Jeantet advised Ananda Impact Ventures and Contrarian Ventures on the EUR 3.6 million seed round of Decade Energy. Decade Energy is a French start-up providing logistics companies with holistic, reliable and cost-efficient solutions that enable the electrification of commercial electric vehicle fleets, aiming to the decarbonation of logistic fleets. The company is headquartered in Paris, […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advised PLENIUM PARTNERS and SWEN CAPITAL PARTNERS in the fundraising of €87 million of SMART ENERGIES to accelerate its development

Paris, 7 June, 2024 – Jeantet advised Plenium Partners’ and SWEN Capital Partners’ funds in their investment in Smart Energies, a French leading solar IPP, alongside the long-standing historical shareholders of Smart Energies, and RGREEN INVEST, which has supported the group since 2022. The capital increase amounts to €87 million and will accelerate the deployment […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advises PULLUP ENTERTAINMENT in the context of its share capital increase without preferential subscription rights by way of a public offering and with a priority period, on an irreducible basis only, for its existing shareholders, for a total amount of circa €23 million

Paris, May 31, 2024 – Jeantet advised PulluP Entertainment, one of the European leaders in the publishing and development of video games iii – AA for PC and Consoles, in the context of its share capital increase without preferential subscription rights of the shareholders by way of a public offering and with a priority period, […]

Paris | CAPITAL MARKETS AND STOCK EXCHANGE LAW

+

Jeantet advises OSMOZIS and its controlling shareholders in the context of the entry into exclusive negotiations with the PASSMAN GROUP for the acquisiton by the PASSMAN GROUP of a majority block, prior to the filing of a simplified tender offer on OSMOZIS shares

Paris, May 24, 2024 – Jeantet has advised Osmozis (a company listed on the Euronext Growth Paris market), specialized in the digital transformation of campsites and holiday homes in Europe, as well as its controlling shareholders, in the context of the acquisition project of a majority block of Osmozis shares by the Passman Group, a […]

| CAPITAL MARKETS AND STOCK EXCHANGE LAW

+

Jeantet advised SEE YOU SUN on its EUR 46 MILLION fundraising

Paris, 6 May, 2024 – Jeantet advised See You Sun, a photovoltaic developer and producer, on a new EUR 46 million round of financing with la Banque des Territoires and Demeter (its historical investors). This new round of financing which follows an initial fundraising of EUR 12 million in 2021 establishes to EUR 58 million […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advises DEUTSCHE TELEKOM on its partnership with EQUATIV

Paris, April 25 2024 – Jeantet advised Deutsche Telekom on its partnership with Equativ, the leading independent adtech platform for programmatic advertising, in which Bridgepoint Development Capital is the majority shareholder. This is a strategic alliance between the French adtech company Equativ and the German telecom giant Deutsche Telekom. By combining their strengths and expertise, […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advised OMNES in setting up its partnership with STONEHEDGE

Paris, 15 April, 2024 – Jeantet advised Omnes, a leading private equity firm dedicated to energy transition and innovation, in the context of its partnership with Stonehedge to create Mégalithe, a joint venture dedicated to developing Class A logistics projects with high environmental standards in France. Through Construction Energie Plus 2, its fund dedicated to […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advises the GIFI group on its 100% takeover of BRICOLEX

Paris, April 4, 2024 – After having advised it, in the course of 2023, on its acquisition of a minority stake, Jeantet advised the Gifi group, specialized in the retail distribution of home decoration and bazaar products under the “Gifi” brand, on its 100% takeover of Le Chamois, specialized in the retail sale of do-it-yourself […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advises 2CRSi in the context of its share capital increase by way of private placement with a public offering aimed at retail investors (via the Primarybid platform) for a total amount of €12 million

Paris, March 20, 2024 – Jeantet advised 2CRSi in the context of its share capital increase by way of private placement to qualified investors with a public offering aimed at retail investors via the PrimaryBid platform on Euronext Growth Paris, for a total amount of €12 million. The total demand for the transaction amounted to […]

Paris | CAPITAL MARKETS AND STOCK EXCHANGE LAW

+

Jeantet advises ENERTIME in the context of its share capital increase without preferential subscription rights by way of a public offering and with a priority period for its existing shareholders on Euronext Growth Paris

Paris, March 8, 2024 – Jeantet advised Enertime in the context of its share capital increase without preferential subscription rights of the shareholders by way of a public offering and with a priority period, on an irreducible and reducible basis, for its shareholders and of a global placement on Euronext Growth Paris, for a total […]

Paris | CAPITAL MARKETS AND STOCK EXCHANGE LAW

+

Jeantet advised JUNGBUNZLAUER group in the context of the acquisition of ALLIANCE GUMS & INDUSTRIES from ROQUETTE group

Paris, 1 March 2024 – Jeantet advised Jungbunzlauer group on the acquisition of Alliance Gums & Industries from Roquette Ventures, part of the Roquette group. On February 29, 2024, Jungbunzlauer group completed the acquisition of Alliance Gums & Industries from Roquette Ventures, part of the Roquette group. Alliance Gums & Industries is an expert blending […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advised MOBILITY TRADER HOLDING in the context of the sale of CARIZY to COFIDIS GROUP

Paris, 2 February 2024 – Jeantet advised Mobility Trader Holding GmbH, the parent company of the heycar group (Berlin, Germany), held by the Volkswagen, Allianz and Renault groups on the sale of Carizy SAS to the Cofidis group. On January 31, 2024, Mobility Trader Holding GmbH, the parent company of the heycar group (Berlin Germany), […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+